Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$25.61 +0.32 (+1.27%)
As of: Oct 2, 2026 · 10:18 AM EDT

Arcutis Biotherapeutics (ARQT) Depreciation & Amortization (CF) (2019 - 2025)

Updated

Arcutis Biotherapeutics' Depreciation & Amortization (CF) was $153,000 in Q1 2025, down 10.0% from $170,000 a year earlier but up 5.5% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends

On a trailing twelve-month basis, Arcutis Biotherapeutics' Depreciation & Amortization (CF) was $623,000 through Mar 31, 2025, down 21.6% year-over-year; for FY2024, it was $640,000, down 20.0% from FY2023.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 56.6% (FY2019 to FY2024).
  • In earlier years, Depreciation & Amortization (CF) was $800,000 in FY2023 (+28.6%), $622,000 in FY2022 (+24.4%), $500,000 in FY2021 (+309.8%) and $122,000 in FY2020 (+79.4%).
  • Quarterly Depreciation & Amortization (CF) has moved between $30,000 (Q2 2020) and $227,000 (Q4 2023) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for five straight quarters, with growth averaging 1.4% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2021 (growth of 420.0%); the worst was Q4 2024 (a decline of 36.1%).
  • Per Business Quant data, ARQT's Depreciation & Amortization (CF) in the three quarters before Q1 2025 was $145,000 (Q4 2024), $161,000 (Q3 2024) and $164,000 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Arcutis Biotherapeutics 3.32 Bn 2.60 Bn 118.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 153,000.00
Dec 31, 2024 145,000.00
Sep 30, 2024 161,000.00
Jun 30, 2024 164,000.00
Mar 31, 2024 170,000.00
Dec 31, 2023 227,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 198,000.00
Mar 31, 2023 175,000.00
Dec 31, 2022 160,000.00
Sep 30, 2022 157,000.00
Jun 30, 2022 155,000.00
Mar 31, 2022 150,000.00
Dec 31, 2021 182,000.00
Sep 30, 2021 116,000.00
Jun 30, 2021 104,000.00
Mar 31, 2021 98,000.00
Dec 31, 2020 35,000.00
Sep 30, 2020 30,000.00
Jun 30, 2020 30,000.00
API Access

Arcutis Biotherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ARQT&period=max&api_key=YOUR_API_KEY